Literature DB >> 345443

Rejection of male skin grafts by splenectomized female mice.

T A Coons, E H Goldberg.   

Abstract

Female mice of the C3H strain normally do not reject skin grafts from males of the same strain; however, 40 percent of splenectomized C3H female mice completely rejected C3H male skin grafts applied 2 weeks later. All splenectomized females showed at least transitory signs of graft rejection.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 345443     DOI: 10.1126/science.345443

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  7 in total

1.  The influence of graft size on the induction of immunity versus tolerance to H-Y in H-2k strains of mice.

Authors:  R B Ashman
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

2.  Primary immune responses to H-Y in BALB/c-H-2k mice.

Authors:  R B Ashman
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

3.  The spleen is required for the suppression of experimental allergic encephalomyelitis by prostaglandin precursors.

Authors:  J Mertin; A Stackpoole
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

4.  Effects of BCG, levamisole and PS-K on the rejection of male skin grafts by female mice.

Authors:  S Seo; J Yasuhara; K Saeki
Journal:  Agents Actions       Date:  1979-10

5.  Influence of the thymus on the capacity of female mice to reject male skin grafts.

Authors:  E S De Pirro; E H Goldberg
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

6.  Tolerance and lymphoid organ structure and function.

Authors:  Bryna E Burrell; Yaozhong Ding; Yumi Nakayama; Kyung-Su Park; Jiangnan Xu; Na Yin; Jonathan S Bromberg
Journal:  Front Immunol       Date:  2011-12-07       Impact factor: 7.561

7.  Induction of anterior chamber-associated immune deviation requires an intact, functional spleen.

Authors:  J W Streilein; J Y Niederkorn
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.